Skip to content

EUMEDICA

Active
Public limited companyfounded 195175 yrs activeChemin de la Nauwelette 1, 7170 Manage, BelgiumKBO/BCE: BE 0403.057.665
Summary

EUMEDICA has been active since 1951 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €26.3m and a net result of €7.2m. Equity is growing by ~9.6% per year across the filed fiscal years. Its solvency ranks better than 47% of 6016 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Risk analysisWatch ReportCompare
EUMEDICAActiveChecked score 97/100
Risk analysis ReportCompare

Overview

Activity
Wholesale of pharmaceutical and medical goods
NACE 46460NACE 51460
#1 company by equity in Manage, Wholesale and retail trade sector2 sites
Size
€81.2mturnover 2025
Staff
155.6 FTE
Equity
€26.3m
Profit
€7.2m
Financial health
97 Excellent Checked score 2025
Bankruptcy chance 12 m
0.1%
Structure
Parent
INVESTPHAR HOLDING LUXEMBOURG S.A.
Auditor: BMS & C°Accounts 16 d early1 of 22 deeds read
Why 97- 1 change of registered office in 24 months+ Size: turnover €81.2m, 155.6 FTE, total assets €61.2m+ Liquidity: current ratio 1.48, cash €14.8m+ Founded in 1951Show the evidence

Checked score

Score 2025
97 / 100
Excellent
Probability in this band: under 0.55%
Better than 75% of its sector peers (NACE 46, medium-sized)
Performance against the sector, not lower risk
Every signal that weighs is under Signals.
Financial strength · tick = 2024
Strong
Solvency 68+1
equity 43.0% of total assets
Liquidity 59+9
short-term debt 44.3% · cash 24.2%
Profitability 82+3
return on assets 11.7%
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.2% (747 companies)
Last 24 months 11-2024: 0.1% 12-2024: 0.1%● 0.0% vs 11-2024 01-2025: 0.1%● 0.0% vs 12-2024 02-2025: 0.1%▼ -4.8% vs 01-2025 03-2025: 0.1%● 0.0% vs 02-2025 04-2025: 0.1%▼ -5.0% vs 03-2025 05-2025: 0.1%▲ +5.3% vs 04-2025 06-2025: 0.1%▼ -3.3% vs 05-2025 07-2025: 0.1%▲ +39.7% vs 06-2025 08-2025: < 0.1%▼ -43.2% vs 07-2025lowest value 09-2025: < 0.1%● 0.0% vs 08-2025lowest value 10-2025: < 0.1%● 0.0% vs 09-2025lowest value 11-2025: < 0.1%● 0.0% vs 10-2025lowest value 12-2025: 0.1%▲ +165% vs 11-2025 01-2026: 0.1%● 0.0% vs 12-2025 02-2026: 0.1%▼ -4.1% vs 01-2026 03-2026: 0.1%● 0.0% vs 02-2026 04-2026: 0.1%▼ -0.9% vs 03-2026 05-2026: 0.1%▲ +24.1% vs 04-2026 06-2026: 0.1%▼ -2.1% vs 05-2026 07-2026: 0.1%▲ +3.5% vs 06-2026highest value 08-2026: 0.1%▼ -39.0% vs 07-2026 09-2026: 0.1%● 0.0% vs 08-2026 10-2026: 0.1%● 0.0% vs 09-2026
  • 1 change of registered office in 24 months raises the probability
  • Size: turnover €81.2m, 155.6 FTE, total assets €61.2m lowers the probability for this profile
  • Liquidity: current ratio 1.48, cash €14.8m lowers the probability
  • Founded in 1951 lowers the probability for this profile
Credit up to €2,550,000 at 30 days acceptable
Liquidity tight (current ratio 1.48 against 1.46 in 2024; short-term debt: 44.3% and cash: 24.2% of total assets), and 57% of the assets are financed with debt.
How it is calculated

The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 46, medium-sized). Better than this share of them on solvency 54%, liquidity 87%, profitability 91%, growth against the median 67%. That is performance, not lower risk; the band itself always comes from the probability.

Bankruptcy probability: model pd-v3.202610021621, computed on 03-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.

Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · 1 change of registered office in 24 months
In the bankruptcy model this factor raises the probability.
Belgian State Gazette
lowers risk · Size: turnover €81.2m, 155.6 FTE, total assets €61.2m
In the bankruptcy model this factor lowers the probability for this profile.
NBB · annual accounts
lowers risk · Liquidity: current ratio 1.48, cash €14.8m
In the bankruptcy model this factor lowers the probability.
NBB · annual accounts
lowers risk · Founded in 1951
In the bankruptcy model this factor lowers the probability for this profile.
KBO
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 15-07-2026, 16 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
16 d early
2024
15 d early
2023
23 d late
2022
9 d late
2021
45 d late
2020
30 d late
2019
34 d late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 16 days after the deadline; the sector median for financial year 2024 is 3 days before the deadline, and 39% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 9 August (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
04-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · full…
  2. Reappointment: BMS & C° SRL (commissaire…State Gazette act
  3. Highest result since 2018net €7.2m ▲23%

Key points

  • Positive: Company by equity in Manage, Wholesale and retail…in the Checked rankings #1 View
  • Positive: 8 profitable years in a rowprofit 2025: €7.2m 8 years View
  • Controlled by INVESTPHAR HOLDING LUXEMBOURG S.A. parent View
  • Active since 1951founded 01-01-1951 75 years View

By topic

Financials

Fiscal year
2025
Turnover
€81.2m
Profit
€7.2m
Solvency
43.0%
Turnover▲ 2.8%
Net result
20182025
Go to Financials

Timeline

Events
14
Since
2017
Next accounts
by 31-07-2027
  1. 15-07-2026Annual accounts filed
  2. 12-03-2026Reappointment: BMS & C° SRL (commissaire aux…
  3. 31-12-2025Highest result since 2018
Go to Timeline

Company details

Sites
2
Legal form
Public limited company
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460
Founded
01-01-1951
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Is the workforce growing, and do people stay?Employer check Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure